NEWS & ARTICLES
OM1 Named to CIOReview Top 100 Big Data Providers 2017
AUG 22, 2017
BOSTON, August 22, 2017 — OM1 has been recognized by CIOReview Magazine as one of the top 100 most promising big data solution providers in 2017. OM1 was nominated and ultimately selected following CIOReview’s annual comprehensive review process. CIOReview’s editorial team analyzed approximately 1,000 companies that provide big data solutions and are at the forefront[…]
Big Ideas for Big Data Analytics in Real-World Evidence
AUG 9, 2017
Published August 9 – by HealthEconomics.com Dr. Patti Peeples, CEO of HealthEconomics.Com, sat down with Dr. Rich Gliklich, CEO of OM1, to discuss how big data analytics are changing the face of real world evidence (RWE). HealthEcoOM1logonomics.Com asked Dr. Gliklich to shares his views on major transformational changes in evidence development and how these will[…]
WHITE PAPERS
From Big Data to Measurable Outcomes: OBC
JUL 6, 2017
A heightened focus on value is driving efforts across health care to improve outcomes and reduce costs. For pharmaceutical companies, this focus translates into a shift away from traditional payment models to more outcomes-based, risk sharing agreements. In many ways, these agreements present the opportunity to better align interests across health care’s stakeholders. However, they[…]
Improving Performance under Bundled Care
NOV 5, 2016
The field of medicine is changing rapidly due to two major disruptions – the application of artificial intelligence, such as machine and deep learning and the shift from fee-for-service to value-based payment models. These innovations, which are occurring simultaneously, are fundamentally altering how data are used and how care is provided. To survive in this[…]
WEBINARS
September 26 – Next Generation Registries: Big Data, Advanced Technologies, More Powerful Evidence
AUG 22, 2017
September 26, 2017 at 2 pm ET – Registries continue to be a critical part of the real-world evidence equation, but over time they have become too trialized, too burdensome, and too separated from real clinical practice. Emerging methodologies, data digitization, and cognitive technologies have set the path for drastic changes needed to address these[…]
September 19 – Big Data and Cognitive Computing: The Next Generation of RWE for Rheumatology & Related Immunologic Disorders
AUG 22, 2017
September 19, 2017 – 10 am ET Join Kathryn Starzyk, Senior Director of Research and Epidemiology, at OM1, as she discusses the evolving role of big data and cognitive computing in generating real-world evidence for rheumatology and related immunologic disorders. This session will explore how advanced technologies and approaches can be applied to support real-world[…]